Randomised phase II trial of stereotactic body radiotherapy in combination with check point inhibitors in metastatic castration-resistant pro state cancer (CheckPRO): a study protocol.
Nicklas Juel SpindlerGitte Fredberg PerssonSusann TheileDorte Lisbeth NielsenEstrid V HøgdallGina Al-FarraHelle Westergren HendelTorben LorentzenInge Marie SvaneHenriette LindbergRikke Løvendahl EefsenPublished in: BMJ open (2023)
gov ID NCT05655715.